Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page
- CheckyesterdayChange DetectedRecruitment is now closed (no longer looking for participants) and the record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.3%

- Check8 days agoChange DetectedA new revision label 'Revision: v3.5.5' was added to the page history. The previous label 'Revision: v3.5.4' was removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.5.4 has been added to the Study Record Versions, and the previous revision v3.5.3 has been removed from the history. This updates the revision history to reflect the latest submission.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision label updates from “v3.5.2” to “v3.5.3,” reflecting a change in the site’s display/versioning rather than the underlying study record.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.